Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report for Connecticut by County

Breast (Late Stage^), 2014-2018

All Races (includes Hispanic), Female, All Ages

Sorted by CI*Rank
 sort alphabetically by name ascending
Met Healthy People Objective of 42.1?
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
(95% Confidence Interval)
 sort by CI rank ascending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
Connecticut 3 Yes 40.8 (39.5, 42.0) N/A 923 28.1
US (SEER+NPCR) 1 Yes 41.7 (41.6, 41.8) N/A 79,558 31.9
Litchfield County 7 Yes 37.2 (32.3, 42.6) 8 (3, 8) 49 26.1
Windham County 7 Yes 37.7 (31.4, 45.0) 7 (1, 8) 27 30.5
New Haven County 7 Yes 38.2 (35.8, 40.6) 6 (4, 8) 211 27.4
Middlesex County 7 Yes 38.7 (33.4, 44.7) 5 (1, 8) 44 25.1
Tolland County 7 Yes 39.1 (33.2, 45.8) 4 (1, 8) 34 26.3
New London County 7 No 42.4 (37.9, 47.3) 3 (1, 6) 71 30.6
Fairfield County 7 No 42.5 (40.1, 45.1) 2 (1, 5) 246 28.0
Hartford County 7 No 42.7 (40.2, 45.3) 1 (1, 5) 240 29.3
Created by on 11/29/2021 1:41 am.

State Cancer Registries may provide more current or more local data.
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The 1969-2018 US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Coding is generally based on Surveillance, Epidemiology, and End Results (SEER) summary stage but may include other staging variables if necessary.
Healthy People 2020 Objectives provided by the Centers for Disease Control and Prevention.

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2018) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2020 submission.
3 Source: SEER November 2020 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
7 Source: SEER November 2020 submission.

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data for United States does not include Puerto Rico.

When displaying county information, the CI*Rank for the state is not shown because it's not comparable. To see the state CI*Rank please view the statistics at the US By State level.

Return to Top